Voyageur Pharmaceuticals (CVE:VM) Shares Down 33.3% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price traded down 33.3% on Wednesday . The company traded as low as C$0.14 and last traded at C$0.16. 1,601,925 shares traded hands during mid-day trading, an increase of 200% from the average session volume of 534,757 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The company has a market cap of C$23.01 million, a price-to-earnings ratio of -16.50 and a beta of 0.32. The business has a 50-day simple moving average of C$0.10 and a two-hundred day simple moving average of C$0.07. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.